


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:47:35Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405543" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405543</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>scirep</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405543</article-id><article-id pub-id-type="pmcid-ver">PMC12405543.1</article-id><article-id pub-id-type="pmcaid">12405543</article-id><article-id pub-id-type="pmcaiid">12405543</article-id><article-id pub-id-type="pmid">40897759</article-id><article-id pub-id-type="doi">10.1038/s41598-025-16770-3</article-id><article-id pub-id-type="publisher-id">16770</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Compensatory retinal blood flow enhancement in cognitively normal ApoE &#949;4 carriers</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="J">Jing</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Cao</surname><given-names initials="Q">Qiuchen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="W">Weijie</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="S">Shige</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="S">Siyu</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Du</surname><given-names initials="X">Xinyu</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="Y">Yanchi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="X">Xinyang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gu</surname><given-names initials="W">Wenting</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhong</surname><given-names initials="J">Jin</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="X">Xinran</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yan</surname><given-names initials="P">Pneg</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Liu</surname><given-names initials="Q">Qinghuai</given-names></name><address><email>liuqh@njmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wu</surname><given-names initials="T">Ting</given-names></name><address><email>wuting80000@126.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04py1g812</institution-id><institution-id institution-id-type="GRID">grid.412676.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1799 0784</institution-id><institution>Department of Ophthalmology, </institution><institution>The First Affiliated Hospital With Nanjing Medical University, </institution></institution-wrap>Nanjing, 210029 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04py1g812</institution-id><institution-id institution-id-type="GRID">grid.412676.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1799 0784</institution-id><institution>Department of Neurology, </institution><institution>The First Affiliated Hospital With Nanjing Medical University, </institution></institution-wrap>Nanjing, 210029 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04523zj19</institution-id><institution-id institution-id-type="GRID">grid.410745.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1765 1045</institution-id><institution>Department of Neurology, The Second Hospital of Nanjing, </institution><institution>Nanjing University of Chinese Medicine, </institution></institution-wrap>Nanjing, 210003 China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/059gcgy73</institution-id><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution>Department of Ophthalmology, Suzhou Municipal Hospital, </institution><institution>The Affiliated Suzhou Hospital of Nanjing Medical University, </institution></institution-wrap>Suzhou, China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">478255</issue-id><elocation-id>32349</elocation-id><history><date date-type="received"><day>25</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="41598_2025_Article_16770.pdf"/><abstract id="Abs1"><p id="Par1">This study aims to compare retinal vascular characteristics between ApoE &#949;4 carriers and non-carriers in healthy individuals. A total of 84 cognitively healthy subjects&#8212;64 non-carriers and 20 carriers of the ApoE &#949;4 allele&#8212;were analyzed using swept-source optical coherence tomography angiography (SS-OCTA). In the retinal vascular layer of OCTA images, parameters such as foveal avascular zone (FAZ) area, vessel perimeter, acircularity index (AI), and vascular density (FD) were quantified. Additionally, blood flow areas in the outer retina and choroidal capillaries, as well as the area without perfusion in the superficial vascular complex (SVC), were measured. Compared to non-carriers, carriers of ApoE &#949;4 exhibited significant reductions in the FAZ area, as well as increased foveal vessel density in both the deep and superficial vascular complexes. No significant differences were observed in AI, FD, blood perfusion area, or perifoveal blood vessel density between the groups. These findings suggest that reduced FAZ area and increased foveal blood flow density in ApoE &#949;4 carriers may indicate a compensatory mechanism in retinal blood flow, potentially serving as early indicators of Alzheimer&#8217;s disease (AD).</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1038/s41598-025-16770-3.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Retinal blood flow</kwd><kwd>ApoE &#949;4 carriers</kwd><kwd>Alzheimer&#8217;s disease</kwd><kwd>Brain and eye</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Cognitive ageing</kwd><kwd>Cognitive neuroscience</kwd><kwd>Diseases of the nervous system</kwd></kwd-group><funding-group><award-group><funding-source><institution>the National Natural Science Foundation of China</institution></funding-source><award-id>81971237</award-id><principal-award-recipient><name name-style="western"><surname>Wu</surname><given-names>Ting</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>he Jiangsu Municipal Science and Technology Bureau</institution></funding-source><award-id>BE2017734</award-id><principal-award-recipient><name name-style="western"><surname>Wu</surname><given-names>Ting</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>the Key Project of Jiangsu Province&#8217;s Key Research and Development Program</institution></funding-source><award-id>BE2023023-2</award-id><principal-award-recipient><name name-style="western"><surname>Wu</surname><given-names>Ting</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec87"><title>Introduction</title><p id="Par2">
Alzheimer&#8217;s disease (AD) is a prevalent neurodegenerative disorder and ranks as a leading cause of dementia among the elderly population<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. Driven by global population aging, AD prevalence and incidence are rising sharply, with worldwide cases projected to escalate from 46.8 million in 2015 to over 1.315 billion by 2050<sup><xref ref-type="bibr" rid="CR2">2</xref>&#8211;<xref ref-type="bibr" rid="CR4">4</xref></sup>. Unfortunately, effective treatments for AD remain elusive; thus, prevention and early intervention have emerged as the most viable strategies to attenuate disease progression. Traditional diagnostic methods, including positron emission tomography (PET) and cerebrospinal fluid (CSF) analysis via lumbar puncture, are the mainstays for diagnosing AD<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. However, patients often view these techniques unfavorably due to their high cost and invasive nature. Consequently, there is an urgent need for the development of non-invasive and cost-effective biomarkers that facilitate timely management and intervention, aiming to delay or prevent cognitive decline and the eventual onset of dementia.</p><p id="Par3">The brain and eyes are closely related, with the retina being an extension of the optic vesicle derived from the neuroectoderm<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Additionally, there are intrinsic anatomical and physiological connections between the brain and eyes, making the eye a true window into brain health<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. Recent studies have shown that pathological changes in the eye are associated with AD, primarily due to the transport of A&#946; from the brain to the eye<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Retinal alterations related to AD, including microvascular abnormalities and retinal layer thinning, may serve as predictive biomarkers for Alzheimer&#8217;s disease<sup><xref ref-type="bibr" rid="CR10">10</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref></sup>. Therefore, there is an urgent need to use the eye as a breakthrough point to observe earlier ocular indicators of brain disease in patients.</p><p id="Par4">The &#603;4 allele of the apolipoprotein E (ApoE) gene is the most prominent genetic risk factor for Alzheimer&#8217;s disease, second only to age<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. Emerging research has shown that the ApoE &#603;4 allele is also associated with cerebral hypoperfusion<sup><xref ref-type="bibr" rid="CR14">14</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>, and a decline in cerebral blood flow (CBF) may precede the onset of clinical symptoms of Alzheimer&#8217;s disease<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup>. However, changes in retinal blood flow among genetically susceptible individuals with Alzheimer&#8217;s disease remain unclear. Therefore, there is an urgent need for systematic ocular clinical observation in cognitively healthy ApoE &#603;4 carriers.</p><p id="Par5">Based on this, we systematically analyzed the differences between ApoE &#603;4 allele carriers and non-carriers by comparing perfusion metrics obtained through swept-source optical coherence tomography angiography (SS-OCTA).</p></sec><sec id="Sec2"><title>Methods</title><p id="Par6">The study protocol is designed as a prospective observational investigation and has received approval from the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University (Approval No: 2022-SR-023). Written informed consent was obtained from all participants. This study adheres to the ethical principles for human experimentation as outlined in the Declaration of Helsinki.</p><sec id="Sec3"><title>Participants</title><p id="Par7">
Participants aged between 50 and 70&#160;years who exhibited no cognitive impairment and demonstrated normal findings on magnetic resonance imaging (MRI) were considered eligible for the study. Cognitive impairment was defined as a score of 25 or lower on the Montreal Cognitive Assessment (MoCA).</p><p id="Par8">Exclusion criteria encompassed a range of medical conditions, including hypertension, diabetes, cancer, and other neurodegenerative disorders such as Parkinson&#8217;s disease and multiple sclerosis. Additionally, ocular exclusions included glaucoma, retinal ischemic conditions, epiretinal membranes (ERM), age-related macular degeneration, macular holes, previous retinal interventions (e.g., pars plana vitrectomy, laser photocoagulation), best corrected visual acuity of less than 20/40 (approximately Log MAR&#8201;=&#8201;0.30), and significant refractive errors exceeding&#8201;&#177;&#8201;3.00 DS (spherical equivalent). Furthermore, images of inadequate quality characterized by a signal strength of less than 6, extensive shadowing, decentration, motion artifacts, and extraneous noise that could hinder quantitative analysis were also excluded.</p></sec><sec id="Sec4"><title>Neuropsychological assessment</title><p id="Par9">Cognitive ability was assessed using the MoCA, a comprehensive and sensitive screening tool that evaluates various cognitive domains, including attention, executive functions, memory, language, visuospatial skills, orientation, calculations, and conceptual reasoning. The maximum score on the MoCA is 30 points, with a score of 26 or higher indicative of normal cognitive function.</p></sec><sec id="Sec5"><title>Genotyping</title><p id="Par10">
Oropharyngeal swab samples were collected for the detection of ApoE genotypes. The genotyping was performed by analyzing two specific single nucleotide polymorphisms (SNPs), rs429358 and rs7412, utilizing the improved multiple ligase detection reaction (imLDR) technique. Participants who possessed one or two ApoE &#949;4 alleles were categorized as ApoE &#949;4 carriers (&#949;4/&#949;4 and &#949;4/&#949;3), while those lacking these alleles were classified as ApoE &#949;4 non-carriers (&#949;2/&#949;2, &#949;2/&#949;3, and &#949;3/&#949;3).</p></sec><sec id="Sec6"><title>Optical coherence tomography angiography</title><p id="Par11">Optical coherence tomography angiography (OCTA) images with a 3&#8201;&#215;&#8201;3&#160; mm configuration, centered on the fovea, were acquired by two skilled ophthalmic technicians using the AngioVue instrument (Optovue RTVue XR Avanti; Optovue, Inc., Fremont, CA, USA). Vascular segmentation was performed automatically through the AngioVue module. A quantitative assessment of the foveal avascular zone (FAZ) index and retinal blood flow area was executed using this advanced instrument.</p><p id="Par12">The FAZ index encompasses several parameters: the FAZ area, the perimeter of the avascular region around the fovea (PERIM), the acircularity index (AI)-defined as the ratio of the measured circumference to the standard circumference of an equal area-and the foveal avascular zone blood density (FD), which refers to the blood flow density within a 300-micron-wide double ring surrounding the FAZ.</p><p id="Par13">The retinal blood flow area was delineated into two regions: the outer retina, spanning from 10&#160;&#181;m below the outer plexiform layer (OPL) to 10&#160;&#181;m above the Bruch&#8217;s membrane (BRM), and the choriocapillaris, extending from 10&#160;&#181;m above the BRM to 30&#160;&#181;m below it. Additionally, the measurement of the Now-Flow area of blood was based on the superficial vascular complex (SVC), extending from the inner limiting membrane (ILM) to 10&#160;&#181;m above the inner plexiform layer (IPL).</p><p id="Par14">Blood perfusion density, which refers to the proportion of the area occupied by blood flow structures, was measured at three different levels: the SVC, deep vascular complex (DVC), and radial peripapillary capillaries (RPC). The macular area was analyzed according to the standard Early Treatment Diabetic Retinopathy Study (ETDRS) macular grid (a foveal area of 1&#160;mm in diameter, 1&#8211;3&#160;mm around the fovea in the inner ring, and 3&#8211;6&#160;mm for the outer ring)<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>.</p></sec><sec id="Sec7"><title>Statistical analyses</title><p id="Par15">
All data analyses were performed using IBM SPSS Statistics for Windows (version 27; IBM Corp) and R software (version 4.3.2). To appropriately address the hierarchical structure of the data-accounting for repeated ocular measurements and inter-individual variability-Generalized Linear Mixed Models (GLMMs) were employed. Model selection involved choosing suitable distribution families and link functions according to the nature of the variables: Linear Mixed Models (LMMs) were applied for continuous variables with approximately normal distributions, while Gamma distributions with log-link functions were used for continuous variables exhibiting non-normal distributions. For multiple group comparisons, estimated marginal means (EMMs) were computed using the &#8216;emmeans&#8217; package in R, with p-values adjusted for multiple testing using the Benjamini&#8211;Hochberg procedure to control the false discovery rate (FDR). Partial correlations, controlling for random effects, were calculated with the &#8216;ppcor&#8217; package to assess inter-variable associations. Linear Mixed Models with random intercepts were further employed to estimate Pearson correlation coefficients for continuous variable relationships. Diagnostic performance of classification models was evaluated via receiver operating characteristic (ROC) curves constructed from predicted probabilities generated by binomial GLMMs with logit link functions using the &#8216;pROC&#8217; package. Optimal cut-off points were determined by maximizing Youden&#8217;s index. The following AUC classification was used in our study: 0.5&#8211;0.6&#8201;=&#8201;unsatisfactory, 0.6&#8211;0.7&#8201;=&#8201;satisfactory, 0.7&#8211;0.8&#8201;=&#8201;good, 0.8&#8211;0.9&#8201;=&#8201;very good, and 0.9&#8211;1&#8201;=&#8201;excellent. A threshold of <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.05 was established to determine statistical significance for all tests conducted.</p></sec></sec><sec id="Sec8"><title>Results</title><p id="Par16">A total of 85 eyes from 64 non-carriers of ApoE &#949;4 and 29 eyes from 20 ApoE &#949;4 carriers were included in the study, with the specific selection process illustrated in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref><bold>.</bold> Females represented a higher proportion of participants, but no significant difference was observed between the groups (64.1% in non-carriers vs. 65.0% in carriers). Similarly, there were no significant differences in age or educational level between the two groups. Demographic data for the subjects are summarized in Table <xref rid="Tab1" ref-type="table">1</xref>. (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Flow diagram illustrating the selection of subjects and eyes. ApoE &#949;4-, noncarriers of &#949;4 allele; ApoE &#949;4&#8201;+&#8201;, carriers of at least one e4 allele. OCTA, optical coherence tomography angiography.</p></caption><graphic id="d33e395" position="float" orientation="portrait" xlink:href="41598_2025_16770_Fig1_HTML.jpg"/></fig><table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Demographics of the participants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variables</th><th align="left" colspan="1" rowspan="1">APOE &#949;4&#8722;(N&#8201;=&#8201;64)</th><th align="left" colspan="1" rowspan="1">APOE &#949;4&#8201;+&#8201;(N&#8201;=&#8201;20)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">P</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age, year (mean&#8201;&#177;&#8201;SD)</td><td align="left" colspan="1" rowspan="1">62.42&#8201;&#177;&#8201;8.077</td><td align="left" colspan="1" rowspan="1">64.5&#8201;&#177;&#8201;7.119</td><td char="." align="char" colspan="1" rowspan="1">0.421*</td></tr><tr><td align="left" colspan="1" rowspan="1">Sex, female (%)</td><td align="left" colspan="1" rowspan="1">41 (64.1%)</td><td align="left" colspan="1" rowspan="1">13 (65.0%)</td><td char="." align="char" colspan="1" rowspan="1">0.939<sup>&#8224;</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Education, secondary and above (%)</td><td align="left" colspan="1" rowspan="1">46 (71.8%)</td><td align="left" colspan="1" rowspan="1">14 (70.0%)</td><td char="." align="char" colspan="1" rowspan="1">0.871<sup>&#8224;</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Family history of AD (%)</td><td align="left" colspan="1" rowspan="1">13(20.3%)</td><td align="left" colspan="1" rowspan="1">8(40.0%)</td><td char="." align="char" colspan="1" rowspan="1">0.076<sup>&#8224;</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Stroke history (%)</td><td align="left" colspan="1" rowspan="1">3(4.6%)</td><td align="left" colspan="1" rowspan="1">3(15.0%)</td><td char="." align="char" colspan="1" rowspan="1">0.287<sup>&#8224;</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Smoking (%)</td><td align="left" colspan="1" rowspan="1">12(18.7%)</td><td align="left" colspan="1" rowspan="1">4(20.0%)</td><td char="." align="char" colspan="1" rowspan="1">0.901<sup>&#8224;</sup></td></tr><tr><td align="left" colspan="1" rowspan="1">Drinking (%)</td><td align="left" colspan="1" rowspan="1">15(23.4%)</td><td align="left" colspan="1" rowspan="1">5(25.0%)</td><td char="." align="char" colspan="1" rowspan="1">0.886<sup>&#8224;</sup></td></tr></tbody></table><table-wrap-foot><p>*Independent samples t-test.</p><p><sup>&#8224;</sup>Chi-square test of independence.</p></table-wrap-foot></table-wrap><fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>30&#8201;&#215;&#8201;30&#176; OCTA images of the central perfusion area at three different levels from a 58-year-old ApoE &#949;4 carrier. <bold>(A)</bold> Foveal blood flow area based on choroidal capillaries, the small red circle is the fovea, and the yellow part indicates the area of blood perfusion; (<bold>B)</bold> Foveal blood flow area based on the outer retina, the small red circle is the fovea, and the yellow part indicates the area of blood perfusion; (<bold>C)</bold> No central perfusion area based on superficial vascular complex, the yellow part shows the area without blood perfusion.</p></caption><graphic id="d33e516" position="float" orientation="portrait" xlink:href="41598_2025_16770_Fig2_HTML.jpg"/></fig></p><sec id="Sec9"><title>Comparison of FAZ index between ApoE &#949;4 carriers and controls</title><p id="Par17">&#65279;Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref> illustrates eye blood perfusion in a 58-year-old woman. In the FAZ index, the FAZ area (mm<sup>2</sup>) was significantly lower in ApoE &#949;4 carriers compared to controls; a trend toward group differences was observed in PERIM (mm) (<italic toggle="yes">p</italic>&#8201;=&#8201;0.05). No statistically significant differences were found between the groups in AI and FD (%) (Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>FAZ index between ApoE &#949;4 carriers and controls. (<bold>A</bold>) The area of the fovea without blood vessels; (<bold>B)</bold> The perimeter of the avascular region around the fovea; (<bold>C)</bold> Acircularity index; (<bold>D)</bold> The blood flow density within a 300-micron-wide double ring surrounding the FAZ.</p></caption><graphic id="d33e551" position="float" orientation="portrait" xlink:href="41598_2025_16770_Fig3_HTML.jpg"/></fig></p></sec><sec id="Sec10"><title>Comparison of retinal blood flow area between ApoE &#949;4 carriers and controls</title><p id="Par18">Within the retinal blood flow area, no differences were observed in Now-Flow area based on SVC, the blood flow area of the outer retina and choriocapillaris between the groups (see Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>Retinal blood flow area between ApoE &#949;4 carriers and controls.<bold> (A)</bold> Foveal blood flow area based on the outer retina; (<bold>B)</bold> Foveal blood flow area based on choroidal capillaries; (<bold>C)</bold> No central perfusion area based on superficial vascular complex.</p></caption><graphic id="d33e575" position="float" orientation="portrait" xlink:href="41598_2025_16770_Fig4_HTML.jpg"/></fig></p></sec><sec id="Sec11"><title>Comparison of blood flow density between ApoE &#949;4 carriers and controls</title><p id="Par19">The blood perfusion density at three different levels including SVC, DVC and RPC were compared (see Figs. <xref rid="Fig5" ref-type="fig">5</xref>, <xref rid="Fig6" ref-type="fig">6</xref> and <xref rid="Fig7" ref-type="fig">7</xref>). The blood perfusion density in the fovea at the SVC and DVC levels was significantly higher in ApoE &#949;4 carriers compared to the control group. Conversely, the blood perfusion density in inside disc of RPC was significantly lower in ApoE &#949;4 carriers. No statistically significant differences in microvascular perfusion density were detected within the peripheral regions at three levels between the two groups (<italic toggle="yes">p</italic>&#8201;&gt;&#8201;0.05).<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><p>Blood Flow Density of the Superficial Vascular Complex Between ApoE &#949;4 Carriers and Controls. (<bold>A)</bold> Whole Image; (<bold>B)</bold> Superior-Hemi; (<bold>C)</bold> Inferior-Hemi; (<bold>D)</bold> Fovea; (<bold>E)</bold> ParaFovea; (<bold>F)</bold> Tempo-ParaFovea; (<bold>G)</bold> Superior-ParaFovea; (<bold>H)</bold> Nasal-ParaFovea; (<bold>I)</bold> Inferior-ParaFovea.</p></caption><graphic id="d33e627" position="float" orientation="portrait" xlink:href="41598_2025_16770_Fig5_HTML.jpg"/></fig><fig id="Fig6" position="float" orientation="portrait"><label>Fig. 6</label><caption><p>Blood Flow Density of Deep Vascular Complex Between ApoE &#949;4 Carriers and Controls.<bold> (A)</bold> Whole Image; (<bold>B)</bold> Superior-Hemi; (<bold>C)</bold> Inferior-Hemi; (<bold>D)</bold> Fovea; (<bold>E)</bold> ParaFovea; (<bold>F)</bold> Tempo-ParaFovea; (<bold>G)</bold> Superior-ParaFovea; (<bold>H)</bold> Nasal-ParaFovea; (<bold>I)</bold> Inferior-ParaFovea.</p></caption><graphic id="d33e663" position="float" orientation="portrait" xlink:href="41598_2025_16770_Fig6_HTML.jpg"/></fig><fig id="Fig7" position="float" orientation="portrait"><label>Fig. 7</label><caption><p>Blood flow density of RPC Between ApoE &#949;4 Carriers and Controls. (<bold>A)</bold> Whole Image; (<bold>B)</bold> Inside Disc; (<bold>C)</bold> Peripapillary; (<bold>D)</bold> Superior-Hemi-Peripapillary; (<bold>E)</bold> Inferior-Hemi-Peripapillary; (<bold>F)</bold> Tempo-Peripapillary; (<bold>G)</bold> Superior-Peripapillary; (<bold>H)</bold> Nasal-Peripapillary; <bold>I</bold> Inferior-Peripapillary.</p></caption><graphic id="d33e700" position="float" orientation="portrait" xlink:href="41598_2025_16770_Fig7_HTML.jpg"/></fig></p></sec><sec id="Sec12"><title>Retinal parameters of ApoE &#949;4 carriers and control group were compared based on gender stratification</title><p id="Par20">Notably, sex-stratified analyses demonstrated that FAZ area was the sole parameter exhibiting significant intergroup divergence among all hemodynamic metrics examined. Post hoc multiple comparisons revealed that both female (0.34&#8201;&#177;&#8201;0.11mm<sup>2</sup>) and male (0.37&#8201;&#177;&#8201;0.13mm<sup>2</sup>) ApoE &#949;4 non-carriers displayed significantly larger FAZ areas compared to male carriers (0.22&#8201;&#177;&#8201;0.10mm<sup>2</sup>) (see Table S2&#8211;S3).</p></sec><sec id="Sec13"><title>Univariate ROC model and multimodal ROC model to distinguish between ApoE &#949;4 carriers and controls</title><p id="Par21">Univariate receiver operating characteristic (ROC) analyses of retinal vascular parameters, including FAZ area, Deep_Fovea, Sup_Fovea, and RPC_In, demonstrated discriminative capacity for identifying ApoE &#949;4 carriers, with FAZ area emerging as the strongest classifier. The FAZ model achieved an area under the curve (AUC) of 0.70 (95% CI: 0.58&#8211;0.81), which remained stable at 0.70 (95% CI: 0.59&#8211;0.80) after model correction (see Fig.&#160;<xref rid="Fig8" ref-type="fig">8</xref>A&#8211;D). A Youden&#8217;s index of 0.38 was utilized to establish a cutoff value of&#8201;&#8804;&#8201;0.33 mm<sup>2</sup> for identifying ApoE &#949;4 carriers, demonstrating a sensitivity of 79.0% and a specificity of 59.0% (see Table S1).<fig id="Fig8" position="float" orientation="portrait"><label>Fig. 8</label><caption><p>ROC Curves for Separation of ApoE &#949;4 Carriers and ApoE &#949;4 Noncarriers Based on Different Retinal Blood Flow Parameters. (<bold>A)</bold> ROC curve illustrating the model based on FAZ area. (<bold>B)</bold> ROC curve illustrating the model based on Deep_Fovea. (<bold>C)</bold> ROC curve illustrating the model based on Sup_Fovea. (<bold>D)</bold> ROC curve illustrating the model based on RPC_In. (<bold>E)</bold> ROC curve illustrating a model incorporating FAZ area, Deep_Fovea, and Sup_Fovea. (<bold>F)</bold> ROC curve illustrating a model incorporating FAZ area, Deep_Fovea, Sup_Fovea, and RPC_In. Deep_Fovea, foveal density of deep vascular complex (DVC); Sup_Fovea, foveal density of superficial vascular complex (SVC).</p></caption><graphic id="d33e746" position="float" orientation="portrait" xlink:href="41598_2025_16770_Fig8_HTML.jpg"/></fig></p><p id="Par22">Furthermore, the multimodal ROC model based on FAZ area, Deep_Fovea, Sup_Fovea, exhibited better classification performance than the univariate ROC analysis (see Fig.&#160;<xref rid="Fig8" ref-type="fig">8</xref>E&#8211;F). Notably, the multimodal ROC model combining FAZ area, Deep_Fovea, Sup_Fovea outperformed a model that included all four retinal parameters (FAZ area, Deep_Fovea, Sup_Fovea, and RPC_In) with an AUC of 0.72 (95% CI&#8201;=&#8201;0.61&#8211;0.82). After model correction, it maintained an AUC of 0.72 (95% CI 0.59&#8211;0.80), achieving a sensitivity of 69.0% and a specificity of 76.0%.</p></sec><sec id="Sec14"><title>Correlation analysis of blood perfusion parameters and blood density parameters in ApoE &#949;4 carriers</title><p id="Par23">Correlation analysis revealed that the FAZ area (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) and PERIM (<italic toggle="yes">p</italic>&#8201;=&#8201;0.0012) were negatively correlated with the central blood flow density of the SVC in ApoE &#949;4 carriers. However, RPC_In showed no significant correlation with the central blood flow density of the SVC) and DVC (Fig.&#160;<xref rid="Fig9" ref-type="fig">9</xref>).<fig id="Fig9" position="float" orientation="portrait"><label>Fig. 9</label><caption><p>The blood perfusion parameters and blood density parameters in ApoE &#949;4 Carriers. (<bold>A&#8211;C)</bold> Linear correlation between FAZ area, PERIM, RPC_In and foveal density of SVC. (<bold>D&#8211;F)</bold> Linear correlation between FAZ area, PERIM, RPC_In and foveal density of DVC. SVC, superficial vascular complex; DVC, deep vascular complex.</p></caption><graphic id="d33e778" position="float" orientation="portrait" xlink:href="41598_2025_16770_Fig9_HTML.jpg"/></fig></p></sec></sec><sec id="Sec15"><title>Discussion</title><p id="Par24">In this study, we identified a significant reduction in the FAZ area and the central blood flow density of RPC among ApoE &#949;4 carriers compared to non-carriers, while blood flow density in the fovea was increased in both the SVC and DVC. Notably, parameters such as the AI, FD, and retinal blood flow in both the outer retina and choriocapillaris exhibited no significant differences between the two groups. Previous studies have shown that female carriers of ApoE &#949;4 experience earlier cognitive decline compared to their male counterparts<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Considering these gender differences, we conducted a further stratified analysis. Sex-stratified analysis demonstrated larger FAZ areas in male and female ApoE &#949;4 non-carriers compared to male carriers.</p><p id="Par25">Additionally, we developed a statistically robust ROC model capable of effectively differentiating ApoE &#949;4 carriers from controls, based on individual analyses of FAZ area, Sup_Fovea, Deep_Fovea, and RPC_In, with the FAZ parameter achieving the highest AUC value. Furthermore, we conducted ROC curve analysis across multiple modalities and found that the multimodal ROC models for the FAZ area, Sup_Fovea, and Deep_Fovea have strong AUC for distinguishing between groups.</p><p id="Par26">Our study found that retinal blood flow significantly increased in ApoE &#949;4 carriers, which contradicts the conclusions of previous research indicating that retinal blood flow perfusion decreases in patients with AD<sup><xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref></sup>. This discrepancy may stem from variations in study design, population characteristics, or stages of the disease. For example, all participants in our study were healthy individuals without significant vascular risk factors, while prior studies often focused on populations with cognitive impairment or those with existing vascular lesions. Additionally, differences in imaging techniques and data analysis methods may also account for the divergent results.</p><p id="Par27">ApoE &#949;4 is one of the primary genetic risk factors for AD, and its influence on blood flow is complex and multifaceted, reflecting a dynamic and adaptive process. In cognitively normal ApoE &#949;4 carriers, the allele may induce an increase in retinal blood flow through various compensatory mechanisms. First, reduced perfusion can trigger a retinal autoregulatory response, leading to macular edema and neovascularization<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR24">24</xref></sup>. Vascular endothelial growth factor (VEGF), which is upregulated under hypoxic conditions, plays a pivotal role in this process<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. VEGF promotes increased blood flow by enhancing endothelial cell survival and regulating vascular permeability<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Notably, studies have demonstrated that VEGF treatment can mitigate cognitive deficits and improve cerebral ischemic function in ApoE &#949;4 female mice, both in the early and late stages of AD pathology<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>. Additionally, the metabolic demands of brain and retinal tissues in ApoE &#949;4 carriers may be elevated<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>, prompting local blood vessels to dynamically adapt to these demands. This adaptation is mediated by mechanisms such as the short-term activation of endothelial nitric oxide synthase (eNOS), which enhances blood supply<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. Furthermore, neuronal metabolic activity can influence blood flow regulation. Interactions between neurons and blood vessels may induce vascular dilation through neurogenic signaling, further augmenting local blood flow<sup><xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref></sup>.</p><p id="Par28">In the late stages of AD, ApoE &#949;4 engages in a mutually reinforcing vicious cycle with cerebrovascular dysfunction through multidimensional pathological mechanisms, which can be summarized as three interconnected pathological axes. First, ApoE &#949;4 disrupts vascular homeostasis via dual pathways: On one hand, it activates the NF-&#954;B pathway to persistently induce the secretion of pro-inflammatory factors such as TNF-&#945; and IL-6<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>, leading to endothelial dysfunction characterized by reduced vasodilation capacity and abnormally increased vascular permeability<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. On the other hand, it suppresses eNOS activity, significantly reducing the synthesis of nitric oxide (NO), a critical mediator of vasodilation<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup>. This dual insult synergistically induces microvascular pathology and cerebral hypoperfusion, laying the pathological foundation for ischemic injury. Second, at the blood&#8211;brain barrier (BBB)-lipid metabolism axis, ApoE &#949;4 activates cyclophilin A in pericytes, triggering the NF-&#954;B/MMP-9 cascade<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, thereby compromising BBB structural integrity. Concurrently, this genotype drives lipid metabolism dysregulation, promoting the abnormal accumulation of atherogenic lipoproteins<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. Such structural-metabolic dual damage markedly exacerbates cerebrovascular degeneration. Notably, ApoE &#949;4 carriers with AD often exhibit reduced cardiac output<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>, suggesting that systemic hemodynamic alterations may accelerate cerebrovascular injury through brain-systemic circulation coupling mechanisms. Third, in the A&#946;-vascular interaction axis, ApoE &#949;4 significantly impairs &#946;-amyloid (A&#946;) clearance efficiency via dysregulated low-density lipoprotein receptor-related protein 1 (LRP1)<sup><xref ref-type="bibr" rid="CR42">42</xref>&#8211;<xref ref-type="bibr" rid="CR45">45</xref></sup>, leading to perivascular A&#946; deposition. These amyloid plaques synergistically amplify vascular pathology by activating oxidative stress pathways and upregulating endothelin-1 expression<sup><xref ref-type="bibr" rid="CR46">46</xref>&#8211;<xref ref-type="bibr" rid="CR48">48</xref></sup>, ultimately causing decompensation of cerebrovascular autoregulation<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. This multi-target cascade mechanism reveals that ApoE &#949;4 not only directly accelerates neurodegeneration in late-stage AD but also drives disease progression by constructing a vascular-metabolic-inflammatory network. The complexity of its pathological mechanisms suggests that combined interventions targeting vascular protection, inflammatory modulation, and lipid metabolism balance may offer new directions to overcome current therapeutic limitations.</p><p id="Par29">Although we found no significant sex-based differences in retinal blood flow among ApoE &#949;4 carriers, numerous previous studies have established that female ApoE &#949;4 carriers exhibit significant gender-specific differences in the progression of AD, with distinct patterns of cognitive decline and pathological mechanisms compared to males. Studies have shown that female carriers face a higher risk of transitioning from normal cognitive status to mild cognitive impairment (MCI) and AD<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup>, which may be closely linked to hormonal fluctuations and metabolic compensation imbalances. During the perimenopausal to postmenopausal stages, declining estrogen levels accelerate amyloid deposition, reduce brain glucose metabolism, and decrease gray and white matter volumes<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Concurrently, compensatory hemodynamic and metabolic adjustments occur, such as increased cerebral blood flow and enhanced ketone metabolism<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. Notably, the cerebrovascular system in female carriers demonstrates dynamic fragility<sup><xref ref-type="bibr" rid="CR54">54</xref>,<xref ref-type="bibr" rid="CR55">55</xref></sup>: hormonal fluctuations during perimenopause lead to transient reductions in blood flow<sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>, while postmenopausal compensatory increases in cerebral blood flow may exacerbate metabolic dysregulation, potentially driving AD progression<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p><p id="Par30">In addition to hemodynamic changes, immune pathological mechanisms further underscore the unique vulnerability of female ApoE &#949;4 carriers. Their immune systems exhibit a paradoxical activation state, with significant elevations in pro-inflammatory factors (e.g., IL-17, IL-1) alongside upregulated immunosuppressive factors (e.g., IL-10, TGF-&#946;)<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. This suggests that compensatory immunosuppression is insufficient to counteract excessive neuroinflammation. Furthermore, abnormal expression of immune checkpoint molecules (e.g., LAG3, PD-1) reflects immune cell exhaustion, which may accelerate neuronal damage<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. Critically, the interplay between hormones and immunity forms a key pathological loop: postmenopausal estrogen decline regulates microglial function and increases susceptibility to A&#946; pathology<sup><xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>, creating a self-reinforcing cycle of &#8220;metabolic dysregulation-immune activation-neuroinflammation.&#8221; However, the temporal and spatial relationships between hemodynamic changes and immune responses, as well as the specific regulatory roles of ApoE &#949;4 in these processes, remain to be elucidated through integrated multi-omics studies.</p><p id="Par31">Our study reveals significant alterations in retinal hemodynamics among ApoE &#949;4 carriers, offering new insights into the role of ApoE &#949;4 in the early pathology of AD. Notably, the changes in retinal blood flow dynamic parameters indicate their potential as novel biomarkers for the early diagnosis of AD. The ROC model developed in this study effectively distinguishes ApoE &#949;4 carriers from the control group. This model serves as an objective detection tool with significant clinical application value for early AD screening.</p><p id="Par32">This study has several limitations: Firstly, its cross-sectional design makes it difficult to establish a causal temporal relationship between ApoE &#949;4-related hemodynamic changes and AD pathology, necessitating validation through longitudinal follow-up studies. Secondly, the exclusion of subjects with vascular risk factors may limit the applicability of the findings to high-risk AD populations. Thirdly, variations in retinal imaging equipment and differing analysis algorithms could affect the comparability of the results, underscoring the need for a standardized detection protocol. Finally, the sample size of the study was small, and there was no in-depth investigation into the specific mechanisms behind the differences in retinal vasculature between groups.</p></sec><sec id="Sec16"><title>Conclusions</title><p id="Par33">In this study, our findings indicate that changes in retinal blood flow could serve as promising early indicators of AD, particularly in individuals with a genetic predisposition. As we strive for non-invasive and effective diagnostic approaches, incorporating ocular assessments into routine clinical practice may significantly enhance our ability to identify those at risk for AD, ultimately supporting the development of timely interventions aimed at mitigating cognitive decline.</p></sec><sec id="Sec108" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="41598_2025_16770_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Material 1.</p></caption></media></supplementary-material>
</p><p>
<supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xlink:href="41598_2025_16770_MOESM2_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 2.</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Jing Zhang and Qiuchen Cao contributed equally as the first authors.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>TW and QHL conceived and proposed the initial hypotheses for the study. QCC, JZ, TW, and QHL designed the study&#8217;s framework. JZ, SIY, and XYD were responsible for recruiting and screening subjects. QHL provided the imaging equipment. QCC, JZ, WJC, SGY and YCW conducted image acquisition and organized the data. JZ, WJC and SGY performed the statistical analysis and interpreted the results. QCC and JZ drafted the initial manuscript, while WYW, WTG, JZ, WRX, PY, TW, and QHL reviewed the manuscript and offered detailed feedback. All authors read and approved the final version of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par34">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lane</surname><given-names>CA</given-names></name><name name-style="western"><surname>Hardy</surname><given-names>J</given-names></name><name name-style="western"><surname>Schott</surname><given-names>JM</given-names></name></person-group><article-title>Alzheimer&#8217;s disease</article-title><source>Eur. J. Neurol.</source><year>2018</year><volume>25</volume><issue>1</issue><fpage>59</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1111/ene.13439</pub-id><pub-id pub-id-type="pmid">28872215</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Lane, C. A., Hardy, J. &amp; Schott, J. M. Alzheimer&#8217;s disease. <italic toggle="yes">Eur. J. Neurol.</italic><bold>25</bold>(1), 59&#8211;70. 10.1111/ene.13439 (2018).<pub-id pub-id-type="pmid">28872215</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ene.13439</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><collab>Alzheimer&#8217;s disease facts and figures</collab></person-group><source>Alzheimers Dement.</source><year>2023</year><volume>19</volume><issue>4</issue><fpage>1598</fpage><lpage>1695</lpage><pub-id pub-id-type="doi">10.1002/alz.13016</pub-id><pub-id pub-id-type="pmid">36918389</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Alzheimer&#8217;s disease facts and figures. <italic toggle="yes">Alzheimers Dement.</italic><bold>19</bold>(4), 1598&#8211;1695. 10.1002/alz.13016 (2023).<pub-id pub-id-type="pmid">36918389</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/alz.13016</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>N</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zou</surname><given-names>L</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Ganoderma lucidum triterpenoids (GLTs) reduce neuronal apoptosis via inhibition of ROCK signal pathway in APP/PS1 transgenic Alzheimer&#8217;s disease mice</article-title><source>Oxid Med. Cell Longev.</source><year>2020</year><volume>2020</volume><fpage>9894037</fpage><pub-id pub-id-type="doi">10.1155/2020/9894037</pub-id><pub-id pub-id-type="pmid">32089787</pub-id><pub-id pub-id-type="pmcid">PMC7008260</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Yu, N. et al. Ganoderma lucidum triterpenoids (GLTs) reduce neuronal apoptosis via inhibition of ROCK signal pathway in APP/PS1 transgenic Alzheimer&#8217;s disease mice. <italic toggle="yes">Oxid Med. Cell Longev.</italic><bold>2020</bold>, 9894037. 10.1155/2020/9894037 (2020).<pub-id pub-id-type="pmid">32089787</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2020/9894037</pub-id><pub-id pub-id-type="pmcid">PMC7008260</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>J-C</given-names></name><name name-style="western"><surname>Tseng</surname><given-names>H-J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S-B</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>K-C</given-names></name><name name-style="western"><surname>Hsin</surname><given-names>L-W</given-names></name><name name-style="western"><surname>Liang</surname><given-names>R-H</given-names></name><etal/></person-group><article-title>Synthesis and biological evaluation of C-4 substituted phenoxazine-bearing hydroxamic acids with potent class II histone deacetylase inhibitory activities</article-title><source>J. Enzyme Inhib. Med. Chem.</source><year>2023</year><volume>38</volume><issue>1</issue><fpage>2212326</fpage><pub-id pub-id-type="doi">10.1080/14756366.2023.2212326</pub-id><pub-id pub-id-type="pmid">37190931</pub-id><pub-id pub-id-type="pmcid">PMC10190190</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Chu, J.-C. et al. Synthesis and biological evaluation of C-4 substituted phenoxazine-bearing hydroxamic acids with potent class II histone deacetylase inhibitory activities. <italic toggle="yes">J. Enzyme Inhib. Med. Chem.</italic><bold>38</bold>(1), 2212326. 10.1080/14756366.2023.2212326 (2023).<pub-id pub-id-type="pmid">37190931</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14756366.2023.2212326</pub-id><pub-id pub-id-type="pmcid">PMC10190190</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>S</given-names></name><name name-style="western"><surname>Barve</surname><given-names>KH</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>MS</given-names></name></person-group><article-title>Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer&#8217;s disease</article-title><source>Curr. Neuropharmacol.</source><year>2020</year><volume>18</volume><issue>11</issue><fpage>1106</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.2174/1570159X18666200528142429</pub-id><pub-id pub-id-type="pmid">32484110</pub-id><pub-id pub-id-type="pmcid">PMC7709159</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Khan, S., Barve, K. H. &amp; Kumar, M. S. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer&#8217;s disease. <italic toggle="yes">Curr. Neuropharmacol.</italic><bold>18</bold>(11), 1106&#8211;1125. 10.2174/1570159X18666200528142429 (2020).<pub-id pub-id-type="pmid">32484110</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1570159X18666200528142429</pub-id><pub-id pub-id-type="pmcid">PMC7709159</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coulombre</surname><given-names>AJ</given-names></name></person-group><article-title>Experimental embryology of the vertebrate eye</article-title><source>Invest. Ophthalmol.</source><year>1965</year><volume>4</volume><fpage>411</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">14340158</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Coulombre, A. J. Experimental embryology of the vertebrate eye. <italic toggle="yes">Invest. Ophthalmol.</italic><bold>4</bold>, 411&#8211;419 (1965).<pub-id pub-id-type="pmid">14340158</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Martin</surname><given-names>E</given-names></name><name name-style="western"><surname>Satue</surname><given-names>M</given-names></name><name name-style="western"><surname>Otin</surname><given-names>S</given-names></name><name name-style="western"><surname>Fuertes</surname><given-names>I</given-names></name><name name-style="western"><surname>Alarcia</surname><given-names>R</given-names></name><name name-style="western"><surname>Larrosa</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Retina measurements for diagnosis of Parkinson disease</article-title><source>Retina</source><year>2014</year><volume>34</volume><issue>5</issue><fpage>971</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1097/IAE.0000000000000028</pub-id><pub-id pub-id-type="pmid">24172914</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Garcia-Martin, E. et al. Retina measurements for diagnosis of Parkinson disease. <italic toggle="yes">Retina</italic><bold>34</bold>(5), 971&#8211;980. 10.1097/IAE.0000000000000028 (2014).<pub-id pub-id-type="pmid">24172914</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/IAE.0000000000000028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Archibald</surname><given-names>NK</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>MP</given-names></name><name name-style="western"><surname>Mosimann</surname><given-names>UP</given-names></name><name name-style="western"><surname>Burn</surname><given-names>DJ</given-names></name></person-group><article-title>The retina in Parkinson&#8217;s disease</article-title><source>Brain</source><year>2009</year><volume>132</volume><issue>Pt 5</issue><fpage>1128</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1093/brain/awp068</pub-id><pub-id pub-id-type="pmid">19336464</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Archibald, N. K., Clarke, M. P., Mosimann, U. P. &amp; Burn, D. J. The retina in Parkinson&#8217;s disease. <italic toggle="yes">Brain</italic><bold>132</bold>(Pt 5), 1128&#8211;1145. 10.1093/brain/awp068 (2009).<pub-id pub-id-type="pmid">19336464</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/awp068</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Transport of &#946;-amyloid from brain to eye causes retinal degeneration in Alzheimer&#8217;s disease</article-title><source>J. Exp. Med.</source><year>2024</year><pub-id pub-id-type="doi">10.1084/jem.20240386</pub-id><pub-id pub-id-type="pmid">39316084</pub-id><pub-id pub-id-type="pmcid">PMC11448872</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Cao, Q. et al. Transport of &#946;-amyloid from brain to eye causes retinal degeneration in Alzheimer&#8217;s disease. <italic toggle="yes">J. Exp. Med.</italic>10.1084/jem.20240386 (2024).<pub-id pub-id-type="pmid">39316084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20240386</pub-id><pub-id pub-id-type="pmcid">PMC11448872</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Golzan</surname><given-names>SM</given-names></name><name name-style="western"><surname>Goozee</surname><given-names>K</given-names></name><name name-style="western"><surname>Georgevsky</surname><given-names>D</given-names></name><name name-style="western"><surname>Avolio</surname><given-names>A</given-names></name><name name-style="western"><surname>Chatterjee</surname><given-names>P</given-names></name><name name-style="western"><surname>Shen</surname><given-names>K</given-names></name><etal/></person-group><article-title>Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer&#8217;s disease</article-title><source>Alzheimers Res. Ther.</source><year>2017</year><volume>9</volume><issue>1</issue><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/s13195-017-0239-9</pub-id><pub-id pub-id-type="pmid">28253913</pub-id><pub-id pub-id-type="pmcid">PMC5335799</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Golzan, S. M. et al. Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer&#8217;s disease. <italic toggle="yes">Alzheimers Res. Ther.</italic><bold>9</bold>(1), 13. 10.1186/s13195-017-0239-9 (2017).<pub-id pub-id-type="pmid">28253913</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13195-017-0239-9</pub-id><pub-id pub-id-type="pmcid">PMC5335799</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Leng</surname><given-names>J</given-names></name><name name-style="western"><surname>&#350;encan-E&#287;ilmez</surname><given-names>I</given-names></name><name name-style="western"><surname>Takase</surname><given-names>H</given-names></name><name name-style="western"><surname>Alfadhel</surname><given-names>MAH</given-names></name><name name-style="western"><surname>Fu</surname><given-names>B</given-names></name><etal/></person-group><article-title>Differential reductions in the capillary red-blood-cell flux between retina and brain under chronic global hypoperfusion</article-title><source>Neurophotonics.</source><year>2023</year><volume>10</volume><issue>3</issue><fpage>035001</fpage><pub-id pub-id-type="doi">10.1117/1.NPh.10.3.035001</pub-id><pub-id pub-id-type="pmid">37323511</pub-id><pub-id pub-id-type="pmcid">PMC10266089</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Li, B. et al. Differential reductions in the capillary red-blood-cell flux between retina and brain under chronic global hypoperfusion. <italic toggle="yes">Neurophotonics.</italic><bold>10</bold>(3), 035001. 10.1117/1.NPh.10.3.035001 (2023).<pub-id pub-id-type="pmid">37323511</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1117/1.NPh.10.3.035001</pub-id><pub-id pub-id-type="pmcid">PMC10266089</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>F</given-names></name><name name-style="western"><surname>Muthy</surname><given-names>ZA</given-names></name><name name-style="western"><surname>Gallacher</surname><given-names>J</given-names></name><name name-style="western"><surname>Sudlow</surname><given-names>C</given-names></name><name name-style="western"><surname>Rees</surname><given-names>G</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Association of retinal nerve fiber layer thinning with current and future cognitive decline: A study using optical coherence tomography</article-title><source>JAMA Neurol.</source><year>2018</year><volume>75</volume><issue>10</issue><fpage>1198</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2018.1578</pub-id><pub-id pub-id-type="pmid">29946685</pub-id><pub-id pub-id-type="pmcid">PMC6233846</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Ko, F. et al. Association of retinal nerve fiber layer thinning with current and future cognitive decline: A study using optical coherence tomography. <italic toggle="yes">JAMA Neurol.</italic><bold>75</bold>(10), 1198&#8211;1205. 10.1001/jamaneurol.2018.1578 (2018).<pub-id pub-id-type="pmid">29946685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2018.1578</pub-id><pub-id pub-id-type="pmcid">PMC6233846</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#243;pez-Cuenca</surname><given-names>I</given-names></name><name name-style="western"><surname>Nebreda</surname><given-names>A</given-names></name><name name-style="western"><surname>Garc&#237;a-Colomo</surname><given-names>A</given-names></name><name name-style="western"><surname>Salobrar-Garc&#237;a</surname><given-names>E</given-names></name><name name-style="western"><surname>de Frutos-Lucas</surname><given-names>J</given-names></name><name name-style="western"><surname>Bru&#241;a</surname><given-names>R</given-names></name><etal/></person-group><article-title>Early visual alterations in individuals at-risk of Alzheimer&#8217;s disease: A multidisciplinary approach</article-title><source>Alzheimers Res. Ther.</source><year>2023</year><volume>15</volume><issue>1</issue><fpage>19</fpage><pub-id pub-id-type="doi">10.1186/s13195-023-01166-0</pub-id><pub-id pub-id-type="pmid">36694201</pub-id><pub-id pub-id-type="pmcid">PMC9872347</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">L&#243;pez-Cuenca, I. et al. Early visual alterations in individuals at-risk of Alzheimer&#8217;s disease: A multidisciplinary approach. <italic toggle="yes">Alzheimers Res. Ther.</italic><bold>15</bold>(1), 19. 10.1186/s13195-023-01166-0 (2023).<pub-id pub-id-type="pmid">36694201</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13195-023-01166-0</pub-id><pub-id pub-id-type="pmcid">PMC9872347</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rawle</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Davis</surname><given-names>D</given-names></name><name name-style="western"><surname>Bendayan</surname><given-names>R</given-names></name><name name-style="western"><surname>Wong</surname><given-names>A</given-names></name><name name-style="western"><surname>Kuh</surname><given-names>D</given-names></name><name name-style="western"><surname>Richards</surname><given-names>M</given-names></name></person-group><article-title>Apolipoprotein-E (Apoe) &#949;4 and cognitive decline over the adult life course</article-title><source>Transl. Psychiatry.</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>18</fpage><pub-id pub-id-type="doi">10.1038/s41398-017-0064-8</pub-id><pub-id pub-id-type="pmid">29317609</pub-id><pub-id pub-id-type="pmcid">PMC5802532</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Rawle, M. J. et al. Apolipoprotein-E (Apoe) &#949;4 and cognitive decline over the adult life course. <italic toggle="yes">Transl. Psychiatry.</italic><bold>8</bold>(1), 18. 10.1038/s41398-017-0064-8 (2018).<pub-id pub-id-type="pmid">29317609</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41398-017-0064-8</pub-id><pub-id pub-id-type="pmcid">PMC5802532</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thambisetty</surname><given-names>M</given-names></name><name name-style="western"><surname>Beason-Held</surname><given-names>L</given-names></name><name name-style="western"><surname>An</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kraut</surname><given-names>MA</given-names></name><name name-style="western"><surname>Resnick</surname><given-names>SM</given-names></name></person-group><article-title>APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging</article-title><source>Arch. Neurol.</source><year>2010</year><volume>67</volume><issue>1</issue><fpage>93</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1001/archneurol.2009.913</pub-id><pub-id pub-id-type="pmid">20065135</pub-id><pub-id pub-id-type="pmcid">PMC2856443</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Thambisetty, M., Beason-Held, L., An, Y., Kraut, M. A. &amp; Resnick, S. M. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging. <italic toggle="yes">Arch. Neurol.</italic><bold>67</bold>(1), 93&#8211;98. 10.1001/archneurol.2009.913 (2010).<pub-id pub-id-type="pmid">20065135</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archneurol.2009.913</pub-id><pub-id pub-id-type="pmcid">PMC2856443</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolters</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Zonneveld</surname><given-names>HI</given-names></name><name name-style="western"><surname>Hofman</surname><given-names>A</given-names></name><name name-style="western"><surname>van der Lugt</surname><given-names>A</given-names></name><name name-style="western"><surname>Koudstaal</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Vernooij</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Cerebral perfusion and the risk of dementia: A population-based study</article-title><source>Circulation</source><year>2017</year><volume>136</volume><issue>8</issue><fpage>719</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.027448</pub-id><pub-id pub-id-type="pmid">28588075</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Wolters, F. J. et al. Cerebral perfusion and the risk of dementia: A population-based study. <italic toggle="yes">Circulation</italic><bold>136</bold>(8), 719&#8211;728. 10.1161/CIRCULATIONAHA.117.027448 (2017).<pub-id pub-id-type="pmid">28588075</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.117.027448</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bracko</surname><given-names>O</given-names></name><name name-style="western"><surname>Cruz Hern&#225;ndez</surname><given-names>JC</given-names></name><name name-style="western"><surname>Park</surname><given-names>L</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>N</given-names></name><name name-style="western"><surname>Schaffer</surname><given-names>CB</given-names></name></person-group><article-title>Causes and consequences of baseline cerebral blood flow reductions in Alzheimer&#8217;s disease</article-title><source>J. Cereb. Blood Flow Metab.</source><year>2021</year><volume>41</volume><issue>7</issue><fpage>1501</fpage><lpage>1516</lpage><pub-id pub-id-type="doi">10.1177/0271678X20982383</pub-id><pub-id pub-id-type="pmid">33444096</pub-id><pub-id pub-id-type="pmcid">PMC8221770</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Bracko, O., Cruz Hern&#225;ndez, J. C., Park, L., Nishimura, N. &amp; Schaffer, C. B. Causes and consequences of baseline cerebral blood flow reductions in Alzheimer&#8217;s disease. <italic toggle="yes">J. Cereb. Blood Flow Metab.</italic><bold>41</bold>(7), 1501&#8211;1516. 10.1177/0271678X20982383 (2021).<pub-id pub-id-type="pmid">33444096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0271678X20982383</pub-id><pub-id pub-id-type="pmcid">PMC8221770</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Grading diabetic retinopathy from stereoscopic color fundus photographs&#8212;An extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5 Suppl):786&#8211;806.<pub-id pub-id-type="pmid">2062513</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>SH</given-names></name><name name-style="western"><surname>Woo</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>C</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Jang</surname><given-names>H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>BC</given-names></name><etal/></person-group><article-title>Disease progression modelling from preclinical Alzheimer&#8217;s disease (AD) to AD dementia</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>4168</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-83585-3</pub-id><pub-id pub-id-type="pmid">33603015</pub-id><pub-id pub-id-type="pmcid">PMC7893024</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Cho, S. H. et al. Disease progression modelling from preclinical Alzheimer&#8217;s disease (AD) to AD dementia. <italic toggle="yes">Sci. Rep.</italic><bold>11</bold>(1), 4168. 10.1038/s41598-021-83585-3 (2021).<pub-id pub-id-type="pmid">33603015</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-83585-3</pub-id><pub-id pub-id-type="pmcid">PMC7893024</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arthur</surname><given-names>E</given-names></name><name name-style="western"><surname>Ravichandran</surname><given-names>S</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Alber</surname><given-names>J</given-names></name><name name-style="western"><surname>Strenger</surname><given-names>J</given-names></name><name name-style="western"><surname>Bittner</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Retinal mid-peripheral capillary free zones are enlarged in cognitively unimpaired older adults at high risk for Alzheimer&#8217;s disease</article-title><source>Alzheimers Res. Ther.</source><year>2023</year><volume>15</volume><issue>1</issue><fpage>172</fpage><pub-id pub-id-type="doi">10.1186/s13195-023-01312-8</pub-id><pub-id pub-id-type="pmid">37828548</pub-id><pub-id pub-id-type="pmcid">PMC10568786</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Arthur, E. et al. Retinal mid-peripheral capillary free zones are enlarged in cognitively unimpaired older adults at high risk for Alzheimer&#8217;s disease. <italic toggle="yes">Alzheimers Res. Ther.</italic><bold>15</bold>(1), 172. 10.1186/s13195-023-01312-8 (2023).<pub-id pub-id-type="pmid">37828548</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13195-023-01312-8</pub-id><pub-id pub-id-type="pmcid">PMC10568786</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corradetti</surname><given-names>G</given-names></name><name name-style="western"><surname>Oncel</surname><given-names>D</given-names></name><name name-style="western"><surname>Kadomoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Arakaki</surname><given-names>X</given-names></name><name name-style="western"><surname>Kloner</surname><given-names>RA</given-names></name><name name-style="western"><surname>Sadun</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Choriocapillaris and retinal vascular alterations in presymptomatic Alzheimer&#8217;s disease</article-title><source>Invest Ophthalmol. Vis. Sci.</source><year>2024</year><volume>65</volume><issue>1</issue><fpage>47</fpage><pub-id pub-id-type="doi">10.1167/iovs.65.1.47</pub-id><pub-id pub-id-type="pmid">38294804</pub-id><pub-id pub-id-type="pmcid">PMC10839815</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Corradetti, G. et al. Choriocapillaris and retinal vascular alterations in presymptomatic Alzheimer&#8217;s disease. <italic toggle="yes">Invest Ophthalmol. Vis. Sci.</italic><bold>65</bold>(1), 47. 10.1167/iovs.65.1.47 (2024).<pub-id pub-id-type="pmid">38294804</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1167/iovs.65.1.47</pub-id><pub-id pub-id-type="pmcid">PMC10839815</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeh</surname><given-names>T-C</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>C-T</given-names></name><name name-style="western"><surname>Chou</surname><given-names>Y-B</given-names></name></person-group><article-title>Retinal microvascular changes in mild cognitive impairment and Alzheimer&#8217;s disease: A systematic review, meta-analysis, and meta-regression</article-title><source>Front. Aging Neurosci.</source><year>2022</year><volume>14</volume><fpage>860759</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2022.860759</pub-id><pub-id pub-id-type="pmid">35572135</pub-id><pub-id pub-id-type="pmcid">PMC9096234</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Yeh, T.-C., Kuo, C.-T. &amp; Chou, Y.-B. Retinal microvascular changes in mild cognitive impairment and Alzheimer&#8217;s disease: A systematic review, meta-analysis, and meta-regression. <italic toggle="yes">Front. Aging Neurosci.</italic><bold>14</bold>, 860759. 10.3389/fnagi.2022.860759 (2022).<pub-id pub-id-type="pmid">35572135</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnagi.2022.860759</pub-id><pub-id pub-id-type="pmcid">PMC9096234</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pournaras</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Rungger-Br&#228;ndle</surname><given-names>E</given-names></name><name name-style="western"><surname>Riva</surname><given-names>CE</given-names></name><name name-style="western"><surname>Hardarson</surname><given-names>SH</given-names></name><name name-style="western"><surname>Stefansson</surname><given-names>E</given-names></name></person-group><article-title>Regulation of retinal blood flow in health and disease</article-title><source>Prog. Retin Eye Res.</source><year>2008</year><volume>27</volume><issue>3</issue><fpage>284</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2008.02.002</pub-id><pub-id pub-id-type="pmid">18448380</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Pournaras, C. J., Rungger-Br&#228;ndle, E., Riva, C. E., Hardarson, S. H. &amp; Stefansson, E. Regulation of retinal blood flow in health and disease. <italic toggle="yes">Prog. Retin Eye Res.</italic><bold>27</bold>(3), 284&#8211;330. 10.1016/j.preteyeres.2008.02.002 (2008).<pub-id pub-id-type="pmid">18448380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.preteyeres.2008.02.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>A</given-names></name><name name-style="western"><surname>Ciulla</surname><given-names>TA</given-names></name><name name-style="western"><surname>Chung</surname><given-names>HS</given-names></name><name name-style="western"><surname>Martin</surname><given-names>B</given-names></name></person-group><article-title>Regulation of retinal and optic nerve blood flow</article-title><source>Arch. Ophthalmol.</source><year>1998</year><volume>116</volume><issue>11</issue><fpage>1491</fpage><lpage>1495</lpage><pub-id pub-id-type="pmid">9823351</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archopht.116.11.1491</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Harris, A., Ciulla, T. A., Chung, H. S. &amp; Martin, B. Regulation of retinal and optic nerve blood flow. <italic toggle="yes">Arch. Ophthalmol.</italic><bold>116</bold>(11), 1491&#8211;1495 (1998).<pub-id pub-id-type="pmid">9823351</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archopht.116.11.1491</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antes</surname><given-names>R</given-names></name><name name-style="western"><surname>Salomon-Zimri</surname><given-names>S</given-names></name><name name-style="western"><surname>Beck</surname><given-names>SC</given-names></name><name name-style="western"><surname>Garcia Garrido</surname><given-names>M</given-names></name><name name-style="western"><surname>Livnat</surname><given-names>T</given-names></name><name name-style="western"><surname>Maharshak</surname><given-names>I</given-names></name><etal/></person-group><article-title>VEGF mediates ApoE4-Induced neovascularization and synaptic pathology in the choroid and retina</article-title><source>Curr. Alzheimer Res.</source><year>2015</year><volume>12</volume><issue>4</issue><fpage>323</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">25817253</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1567205012666150325182504</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Antes, R. et al. VEGF mediates ApoE4-Induced neovascularization and synaptic pathology in the choroid and retina. <italic toggle="yes">Curr. Alzheimer Res.</italic><bold>12</bold>(4), 323&#8211;334 (2015).<pub-id pub-id-type="pmid">25817253</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1567205012666150325182504</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Melincovici</surname><given-names>CS</given-names></name><name name-style="western"><surname>Bo&#351;ca</surname><given-names>AB</given-names></name><name name-style="western"><surname>&#350;u&#351;man</surname><given-names>S</given-names></name><name name-style="western"><surname>M&#259;rginean</surname><given-names>M</given-names></name><name name-style="western"><surname>Mihu</surname><given-names>C</given-names></name><name name-style="western"><surname>Istrate</surname><given-names>M</given-names></name><etal/></person-group><article-title>Vascular endothelial growth factor (VEGF)&#8212;key factor in normal and pathological angiogenesis</article-title><source>Rom. J. Morphol. Embryol.</source><year>2018</year><volume>59</volume><issue>2</issue><fpage>455</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">30173249</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Melincovici, C. S. et al. Vascular endothelial growth factor (VEGF)&#8212;key factor in normal and pathological angiogenesis. <italic toggle="yes">Rom. J. Morphol. Embryol.</italic><bold>59</bold>(2), 455&#8211;467 (2018).<pub-id pub-id-type="pmid">30173249</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaldua</surname><given-names>S</given-names></name><name name-style="western"><surname>Damen</surname><given-names>FC</given-names></name><name name-style="western"><surname>Pisharody</surname><given-names>R</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>R</given-names></name><name name-style="western"><surname>Fan</surname><given-names>KD</given-names></name><name name-style="western"><surname>Ekkurthi</surname><given-names>GK</given-names></name><etal/></person-group><article-title>Epidermal growth factor treatment of female mice that express APOE4 at an age of advanced pathology mitigates behavioral and cerebrovascular dysfunction</article-title><source>Heliyon.</source><year>2020</year><volume>6</volume><issue>5</issue><fpage>e03919</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e03919</pub-id><pub-id pub-id-type="pmid">32478184</pub-id><pub-id pub-id-type="pmcid">PMC7251379</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Zaldua, S. et al. Epidermal growth factor treatment of female mice that express APOE4 at an age of advanced pathology mitigates behavioral and cerebrovascular dysfunction. <italic toggle="yes">Heliyon.</italic><bold>6</bold>(5), e03919. 10.1016/j.heliyon.2020.e03919 (2020).<pub-id pub-id-type="pmid">32478184</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.heliyon.2020.e03919</pub-id><pub-id pub-id-type="pmcid">PMC7251379</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>R</given-names></name><name name-style="western"><surname>Morris</surname><given-names>AWJ</given-names></name><name name-style="western"><surname>Tai</surname><given-names>LM</given-names></name></person-group><article-title>Epidermal growth factor prevents APOE4-induced cognitive and cerebrovascular deficits in female mice</article-title><source>Heliyon.</source><year>2017</year><volume>3</volume><issue>6</issue><fpage>e00319</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2017.e00319</pub-id><pub-id pub-id-type="pmid">28626809</pub-id><pub-id pub-id-type="pmcid">PMC5463012</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Thomas, R., Morris, A. W. J. &amp; Tai, L. M. Epidermal growth factor prevents APOE4-induced cognitive and cerebrovascular deficits in female mice. <italic toggle="yes">Heliyon.</italic><bold>3</bold>(6), e00319. 10.1016/j.heliyon.2017.e00319 (2017).<pub-id pub-id-type="pmid">28626809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.heliyon.2017.e00319</pub-id><pub-id pub-id-type="pmcid">PMC5463012</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Protas</surname><given-names>HD</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Langbaum</surname><given-names>JBS</given-names></name><name name-style="western"><surname>Fleisher</surname><given-names>AS</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>GE</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W</given-names></name><etal/></person-group><article-title>Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease</article-title><source>JAMA Neurol.</source><year>2013</year><volume>70</volume><issue>3</issue><fpage>320</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">23599929</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/2013.jamaneurol.286</pub-id><pub-id pub-id-type="pmcid">PMC3745014</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Protas, H. D. et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. <italic toggle="yes">JAMA Neurol.</italic><bold>70</bold>(3), 320&#8211;325 (2013).<pub-id pub-id-type="pmid">23599929</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/2013.jamaneurol.286</pub-id><pub-id pub-id-type="pmcid">PMC3745014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seddon</surname><given-names>MD</given-names></name><name name-style="western"><surname>Chowienczyk</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Brett</surname><given-names>SE</given-names></name><name name-style="western"><surname>Casadei</surname><given-names>B</given-names></name><name name-style="western"><surname>Shah</surname><given-names>AM</given-names></name></person-group><article-title>Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo</article-title><source>Circulation</source><year>2008</year><volume>117</volume><issue>15</issue><fpage>1991</fpage><lpage>1996</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.744540</pub-id><pub-id pub-id-type="pmid">18391107</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Seddon, M. D., Chowienczyk, P. J., Brett, S. E., Casadei, B. &amp; Shah, A. M. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. <italic toggle="yes">Circulation</italic><bold>117</bold>(15), 1991&#8211;1996. 10.1161/CIRCULATIONAHA.107.744540 (2008).<pub-id pub-id-type="pmid">18391107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.107.744540</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Gallagher</surname><given-names>K</given-names></name><name name-style="western"><surname>Puledda</surname><given-names>F</given-names></name><name name-style="western"><surname>O'Daly</surname><given-names>O</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>M</given-names></name><name name-style="western"><surname>Dancy</surname><given-names>L</given-names></name><name name-style="western"><surname>Chowienczyk</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Neuronal nitric oxide synthase regulates regional brain perfusion in healthy humans</article-title><source>Cardiovasc. Res.</source><year>2022</year><volume>118</volume><issue>5</issue><fpage>1321</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvab155</pub-id><pub-id pub-id-type="pmid">34120160</pub-id><pub-id pub-id-type="pmcid">PMC8953449</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">O&#8217;Gallagher, K. et al. Neuronal nitric oxide synthase regulates regional brain perfusion in healthy humans. <italic toggle="yes">Cardiovasc. Res.</italic><bold>118</bold>(5), 1321&#8211;1329. 10.1093/cvr/cvab155 (2022).<pub-id pub-id-type="pmid">34120160</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/cvr/cvab155</pub-id><pub-id pub-id-type="pmcid">PMC8953449</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>HC</given-names></name><name name-style="western"><surname>Farmer</surname><given-names>BC</given-names></name><name name-style="western"><surname>Piron</surname><given-names>MA</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>AE</given-names></name><name name-style="western"><surname>Bruntz</surname><given-names>RC</given-names></name><name name-style="western"><surname>Gentry</surname><given-names>MS</given-names></name><etal/></person-group><article-title>APOE alters glucose flux through central carbon pathways in astrocytes</article-title><source>Neurobiol. Dis.</source><year>2020</year><volume>136</volume><fpage>104742</fpage><pub-id pub-id-type="doi">10.1016/j.nbd.2020.104742</pub-id><pub-id pub-id-type="pmid">31931141</pub-id><pub-id pub-id-type="pmcid">PMC7044721</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Williams, H. C. et al. APOE alters glucose flux through central carbon pathways in astrocytes. <italic toggle="yes">Neurobiol. Dis.</italic><bold>136</bold>, 104742. 10.1016/j.nbd.2020.104742 (2020).<pub-id pub-id-type="pmid">31931141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nbd.2020.104742</pub-id><pub-id pub-id-type="pmcid">PMC7044721</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>&#216;stergaard</surname><given-names>L</given-names></name><name name-style="western"><surname>Aamand</surname><given-names>R</given-names></name><name name-style="western"><surname>Guti&#233;rrez-Jim&#233;nez</surname><given-names>E</given-names></name><name name-style="western"><surname>Ho</surname><given-names>YCL</given-names></name><name name-style="western"><surname>Blicher</surname><given-names>JU</given-names></name><name name-style="western"><surname>Madsen</surname><given-names>SM</given-names></name><etal/></person-group><article-title>The capillary dysfunction hypothesis of Alzheimer&#8217;s disease</article-title><source>Neurobiol. Aging.</source><year>2013</year><volume>34</volume><issue>4</issue><fpage>1018</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2012.09.011</pub-id><pub-id pub-id-type="pmid">23084084</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">&#216;stergaard, L. et al. The capillary dysfunction hypothesis of Alzheimer&#8217;s disease. <italic toggle="yes">Neurobiol. Aging.</italic><bold>34</bold>(4), 1018&#8211;1031. 10.1016/j.neurobiolaging.2012.09.011 (2013).<pub-id pub-id-type="pmid">23084084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neurobiolaging.2012.09.011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ophir</surname><given-names>G</given-names></name><name name-style="western"><surname>Amariglio</surname><given-names>N</given-names></name><name name-style="western"><surname>Jacob-Hirsch</surname><given-names>J</given-names></name><name name-style="western"><surname>Elkon</surname><given-names>R</given-names></name><name name-style="western"><surname>Rechavi</surname><given-names>G</given-names></name><name name-style="western"><surname>Michaelson</surname><given-names>DM</given-names></name></person-group><article-title>Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade</article-title><source>Neurobiol. Dis.</source><year>2005</year><volume>20</volume><issue>3</issue><fpage>709</fpage><lpage>718</lpage><pub-id pub-id-type="pmid">15979312</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nbd.2005.05.002</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Ophir, G. et al. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade. <italic toggle="yes">Neurobiol. Dis.</italic><bold>20</bold>(3), 709&#8211;718 (2005).<pub-id pub-id-type="pmid">15979312</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nbd.2005.05.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>Y-Y</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Q-L</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Z-Y</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tang</surname><given-names>W</given-names></name><etal/></person-group><article-title>APOE &#949;4 allele elevates the expressions of inflammatory factors and promotes Alzheimer&#8217;s disease progression: A comparative study based on Han and She populations in the Wenzhou area</article-title><source>Brain Res. Bull.</source><year>2017</year><volume>132</volume><fpage>39</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2017.04.017</pub-id><pub-id pub-id-type="pmid">28461186</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Fan, Y.-Y. et al. APOE &#949;4 allele elevates the expressions of inflammatory factors and promotes Alzheimer&#8217;s disease progression: A comparative study based on Han and She populations in the Wenzhou area. <italic toggle="yes">Brain Res. Bull.</italic><bold>132</bold>, 39&#8211;43. 10.1016/j.brainresbull.2017.04.017 (2017).<pub-id pub-id-type="pmid">28461186</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.brainresbull.2017.04.017</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Almutary</surname><given-names>AG</given-names></name><name name-style="western"><surname>Begum</surname><given-names>MY</given-names></name><name name-style="western"><surname>Kyada</surname><given-names>AK</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Jyothi</surname><given-names>SR</given-names></name><name name-style="western"><surname>Chaudhary</surname><given-names>K</given-names></name><etal/></person-group><article-title>Inflammatory signaling pathways in Alzheimer&#8217;s disease: Mechanistic insights and possible therapeutic interventions</article-title><source>Ageing Res Rev.</source><year>2025</year><volume>104</volume><fpage>102548</fpage><pub-id pub-id-type="doi">10.1016/j.arr.2024.102548</pub-id><pub-id pub-id-type="pmid">39419399</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Almutary, A. G. et al. Inflammatory signaling pathways in Alzheimer&#8217;s disease: Mechanistic insights and possible therapeutic interventions. <italic toggle="yes">Ageing Res Rev.</italic><bold>104</bold>, 102548. 10.1016/j.arr.2024.102548 (2025).<pub-id pub-id-type="pmid">39419399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.arr.2024.102548</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seddon</surname><given-names>M</given-names></name><name name-style="western"><surname>Melikian</surname><given-names>N</given-names></name><name name-style="western"><surname>Dworakowski</surname><given-names>R</given-names></name><name name-style="western"><surname>Shabeeh</surname><given-names>H</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>J</given-names></name><etal/></person-group><article-title>Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo</article-title><source>Circulation</source><year>2009</year><volume>119</volume><issue>20</issue><fpage>2656</fpage><lpage>2662</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.822205</pub-id><pub-id pub-id-type="pmid">19433760</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Seddon, M. et al. Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. <italic toggle="yes">Circulation</italic><bold>119</bold>(20), 2656&#8211;2662. 10.1161/CIRCULATIONAHA.108.822205 (2009).<pub-id pub-id-type="pmid">19433760</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.108.822205</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bell</surname><given-names>RD</given-names></name><name name-style="western"><surname>Winkler</surname><given-names>EA</given-names></name><name name-style="western"><surname>Singh</surname><given-names>I</given-names></name><name name-style="western"><surname>Sagare</surname><given-names>AP</given-names></name><name name-style="western"><surname>Deane</surname><given-names>R</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Apolipoprotein E controls cerebrovascular integrity via cyclophilin A</article-title><source>Nature</source><year>2012</year><volume>485</volume><issue>7399</issue><fpage>512</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1038/nature11087</pub-id><pub-id pub-id-type="pmid">22622580</pub-id><pub-id pub-id-type="pmcid">PMC4047116</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Bell, R. D. et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. <italic toggle="yes">Nature</italic><bold>485</bold>(7399), 512&#8211;516. 10.1038/nature11087 (2012).<pub-id pub-id-type="pmid">22622580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature11087</pub-id><pub-id pub-id-type="pmcid">PMC4047116</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahley</surname><given-names>RW</given-names></name><name name-style="western"><surname>Rall</surname><given-names>SC</given-names></name></person-group><article-title>Apolipoprotein E: Far more than a lipid transport protein</article-title><source>Annu. Rev. Genomics Hum. Genet.</source><year>2000</year><volume>1</volume><fpage>507</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">11701639</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.genom.1.1.507</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Mahley, R. W. &amp; Rall, S. C. Apolipoprotein E: Far more than a lipid transport protein. <italic toggle="yes">Annu. Rev. Genomics Hum. Genet.</italic><bold>1</bold>, 507&#8211;537 (2000).<pub-id pub-id-type="pmid">11701639</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev.genom.1.1.507</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>LG</given-names></name><name name-style="western"><surname>March</surname><given-names>ZM</given-names></name><name name-style="western"><surname>Stephenson</surname><given-names>RA</given-names></name><name name-style="western"><surname>Narayan</surname><given-names>PS</given-names></name></person-group><article-title>Apolipoprotein E in lipid metabolism and neurodegenerative disease</article-title><source>Trends Endocrinol Metab.</source><year>2023</year><volume>34</volume><issue>8</issue><fpage>430</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2023.05.002</pub-id><pub-id pub-id-type="pmid">37357100</pub-id><pub-id pub-id-type="pmcid">PMC10365028</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Yang, L. G., March, Z. M., Stephenson, R. A. &amp; Narayan, P. S. Apolipoprotein E in lipid metabolism and neurodegenerative disease. <italic toggle="yes">Trends Endocrinol Metab.</italic><bold>34</bold>(8), 430&#8211;445. 10.1016/j.tem.2023.05.002 (2023).<pub-id pub-id-type="pmid">37357100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tem.2023.05.002</pub-id><pub-id pub-id-type="pmcid">PMC10365028</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bown</surname><given-names>CW</given-names></name><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Osborn</surname><given-names>KE</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>DK</given-names></name><name name-style="western"><surname>Mendes</surname><given-names>LA</given-names></name><name name-style="western"><surname>Pechman</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Apolipoprotein E genotype modifies the association between cardiac output and cognition in older adults</article-title><source>J Am. Heart Assoc.</source><year>2019</year><volume>8</volume><issue>15</issue><fpage>e011146</fpage><pub-id pub-id-type="doi">10.1161/JAHA.118.011146</pub-id><pub-id pub-id-type="pmid">31364446</pub-id><pub-id pub-id-type="pmcid">PMC6761646</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Bown, C. W. et al. Apolipoprotein E genotype modifies the association between cardiac output and cognition in older adults. <italic toggle="yes">J Am. Heart Assoc.</italic><bold>8</bold>(15), e011146. 10.1161/JAHA.118.011146 (2019).<pub-id pub-id-type="pmid">31364446</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/JAHA.118.011146</pub-id><pub-id pub-id-type="pmcid">PMC6761646</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jackson</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Keiser</surname><given-names>MS</given-names></name><name name-style="western"><surname>Meltzer</surname><given-names>JC</given-names></name><name name-style="western"><surname>Fykstra</surname><given-names>DP</given-names></name><name name-style="western"><surname>Dierksmeier</surname><given-names>SE</given-names></name><name name-style="western"><surname>Hajizadeh</surname><given-names>S</given-names></name><etal/></person-group><article-title>APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease</article-title><source>Mol. Ther.</source><year>2024</year><volume>32</volume><issue>5</issue><fpage>1373</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1016/j.ymthe.2024.03.024</pub-id><pub-id pub-id-type="pmid">38504517</pub-id><pub-id pub-id-type="pmcid">PMC11081918</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Jackson, R. J. et al. APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease. <italic toggle="yes">Mol. Ther.</italic><bold>32</bold>(5), 1373&#8211;1386. 10.1016/j.ymthe.2024.03.024 (2024).<pub-id pub-id-type="pmid">38504517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymthe.2024.03.024</pub-id><pub-id pub-id-type="pmcid">PMC11081918</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fongang</surname><given-names>B</given-names></name><name name-style="western"><surname>Sargurupremraj</surname><given-names>M</given-names></name><name name-style="western"><surname>Jian</surname><given-names>X</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>A</given-names></name><name name-style="western"><surname>Damotte</surname><given-names>V</given-names></name><name name-style="western"><surname>de Rojas</surname><given-names>I</given-names></name><name name-style="western"><surname>Skrobot</surname><given-names>O</given-names></name><name name-style="western"><surname>Bis</surname><given-names>JC</given-names></name><name name-style="western"><surname>Fan</surname><given-names>KH</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>E</given-names></name></person-group><article-title>A genome-wide association meta-analysis of all-cause and vascular dementia</article-title><source>Alzheimer&#8217;s Dementia.</source><year>2024</year><volume>20</volume><issue>9</issue><fpage>5973</fpage><lpage>5995</lpage><pub-id pub-id-type="doi">10.1002/alz.14115</pub-id><pub-id pub-id-type="pmcid">PMC11497727</pub-id><pub-id pub-id-type="pmid">39046104</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Fongang, B. et al. A genome-wide association meta-analysis of all-cause and vascular dementia. <italic toggle="yes">Alzheimer&#8217;s Dementia.</italic><bold>20</bold>(9), 5973&#8211;5995. 10.1002/alz.14115 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/alz.14115</pub-id><pub-id pub-id-type="pmcid">PMC11497727</pub-id><pub-id pub-id-type="pmid">39046104</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ossenkoppele</surname><given-names>R</given-names></name><name name-style="western"><surname>Jansen</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Rabinovici</surname><given-names>GD</given-names></name><name name-style="western"><surname>Knol</surname><given-names>DL</given-names></name><name name-style="western"><surname>van der Flier</surname><given-names>WM</given-names></name><name name-style="western"><surname>van Berckel</surname><given-names>BNM</given-names></name><etal/></person-group><article-title>Prevalence of amyloid PET positivity in dementia syndromes: A meta-analysis</article-title><source>JAMA</source><year>2015</year><volume>313</volume><issue>19</issue><fpage>1939</fpage><lpage>1949</lpage><pub-id pub-id-type="doi">10.1001/jama.2015.4669</pub-id><pub-id pub-id-type="pmid">25988463</pub-id><pub-id pub-id-type="pmcid">PMC4517678</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Ossenkoppele, R. et al. Prevalence of amyloid PET positivity in dementia syndromes: A meta-analysis. <italic toggle="yes">JAMA</italic><bold>313</bold>(19), 1939&#8211;1949. 10.1001/jama.2015.4669 (2015).<pub-id pub-id-type="pmid">25988463</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2015.4669</pub-id><pub-id pub-id-type="pmcid">PMC4517678</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>C-C</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>N</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N</given-names></name><name name-style="western"><surname>Linares</surname><given-names>C</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>C-W</given-names></name><etal/></person-group><article-title>ApoE4 accelerates early seeding of amyloid pathology</article-title><source>Neuron</source><year>2017</year><pub-id pub-id-type="doi">10.1016/j.neuron.2017.11.013</pub-id><pub-id pub-id-type="pmid">29216449</pub-id><pub-id pub-id-type="pmcid">PMC5948105</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Liu, C.-C. et al. ApoE4 accelerates early seeding of amyloid pathology. <italic toggle="yes">Neuron</italic>10.1016/j.neuron.2017.11.013 (2017).<pub-id pub-id-type="pmid">29216449</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuron.2017.11.013</pub-id><pub-id pub-id-type="pmcid">PMC5948105</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paris</surname><given-names>D</given-names></name><name name-style="western"><surname>Humphrey</surname><given-names>J</given-names></name><name name-style="western"><surname>Quadros</surname><given-names>A</given-names></name><name name-style="western"><surname>Patel</surname><given-names>N</given-names></name><name name-style="western"><surname>Crescentini</surname><given-names>R</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>F</given-names></name><etal/></person-group><article-title>Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer&#8217;s disease: role of inflammation</article-title><source>Neurol Res.</source><year>2003</year><volume>25</volume><issue>6</issue><fpage>642</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">14503019</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1179/016164103101201940</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Paris, D. et al. Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimer&#8217;s disease: role of inflammation. <italic toggle="yes">Neurol Res.</italic><bold>25</bold>(6), 642&#8211;651 (2003).<pub-id pub-id-type="pmid">14503019</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1179/016164103101201940</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>T</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name><name name-style="western"><surname>McLendon</surname><given-names>C</given-names></name><name name-style="western"><surname>Sutton</surname><given-names>T</given-names></name><name name-style="western"><surname>Mullan</surname><given-names>M</given-names></name></person-group><article-title>beta-Amyloid-mediated vasoactivity and vascular endothelial damage</article-title><source>Nature</source><year>1996</year><volume>380</volume><issue>6570</issue><fpage>168</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">8600393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/380168a0</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Thomas, T., Thomas, G., McLendon, C., Sutton, T. &amp; Mullan, M. beta-Amyloid-mediated vasoactivity and vascular endothelial damage. <italic toggle="yes">Nature</italic><bold>380</bold>(6570), 168&#8211;171 (1996).<pub-id pub-id-type="pmid">8600393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/380168a0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmer</surname><given-names>JC</given-names></name><name name-style="western"><surname>Barker</surname><given-names>R</given-names></name><name name-style="western"><surname>Kehoe</surname><given-names>PG</given-names></name><name name-style="western"><surname>Love</surname><given-names>S</given-names></name></person-group><article-title>Endothelin-1 is elevated in Alzheimer&#8217;s disease and upregulated by amyloid-&#946;</article-title><source>J Alzheimers Dis.</source><year>2012</year><volume>29</volume><issue>4</issue><fpage>853</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.3233/JAD-2012-111760</pub-id><pub-id pub-id-type="pmid">22330820</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Palmer, J. C., Barker, R., Kehoe, P. G. &amp; Love, S. Endothelin-1 is elevated in Alzheimer&#8217;s disease and upregulated by amyloid-&#946;. <italic toggle="yes">J Alzheimers Dis.</italic><bold>29</bold>(4), 853&#8211;861. 10.3233/JAD-2012-111760 (2012).<pub-id pub-id-type="pmid">22330820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-2012-111760</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Meng</surname><given-names>F</given-names></name><name name-style="western"><surname>He</surname><given-names>F</given-names></name><name name-style="western"><surname>Ni</surname><given-names>J</given-names></name><name name-style="western"><surname>Fu</surname><given-names>Y</given-names></name></person-group><article-title>The vascular contribution of apolipoprotein E to Alzheimer&#8217;s disease</article-title><source>Brain</source><year>2024</year><volume>147</volume><issue>9</issue><fpage>2946</fpage><lpage>2965</lpage><pub-id pub-id-type="doi">10.1093/brain/awae156</pub-id><pub-id pub-id-type="pmid">38748848</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Chen, F. et al. The vascular contribution of apolipoprotein E to Alzheimer&#8217;s disease. <italic toggle="yes">Brain</italic><bold>147</bold>(9), 2946&#8211;2965. 10.1093/brain/awae156 (2024).<pub-id pub-id-type="pmid">38748848</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/awae156</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altmann</surname><given-names>A</given-names></name><name name-style="western"><surname>Tian</surname><given-names>L</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>VW</given-names></name><name name-style="western"><surname>Greicius</surname><given-names>MD</given-names></name></person-group><article-title>Sex modifies the APOE-related risk of developing Alzheimer disease</article-title><source>Ann. Neurol.</source><year>2014</year><volume>75</volume><issue>4</issue><fpage>563</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1002/ana.24135</pub-id><pub-id pub-id-type="pmid">24623176</pub-id><pub-id pub-id-type="pmcid">PMC4117990</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Altmann, A., Tian, L., Henderson, V. W. &amp; Greicius, M. D. Sex modifies the APOE-related risk of developing Alzheimer disease. <italic toggle="yes">Ann. Neurol.</italic><bold>75</bold>(4), 563&#8211;573. 10.1002/ana.24135 (2014).<pub-id pub-id-type="pmid">24623176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ana.24135</pub-id><pub-id pub-id-type="pmcid">PMC4117990</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neu</surname><given-names>SC</given-names></name><name name-style="western"><surname>Pa</surname><given-names>J</given-names></name><name name-style="western"><surname>Kukull</surname><given-names>W</given-names></name><name name-style="western"><surname>Beekly</surname><given-names>D</given-names></name><name name-style="western"><surname>Kuzma</surname><given-names>A</given-names></name><name name-style="western"><surname>Gangadharan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Apolipoprotein E genotype and sex risk factors for Alzheimer disease: A meta-analysis</article-title><source>JAMA Neurol.</source><year>2017</year><volume>74</volume><issue>10</issue><fpage>1178</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2017.2188</pub-id><pub-id pub-id-type="pmid">28846757</pub-id><pub-id pub-id-type="pmcid">PMC5759346</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Neu, S. C. et al. Apolipoprotein E genotype and sex risk factors for Alzheimer disease: A meta-analysis. <italic toggle="yes">JAMA Neurol.</italic><bold>74</bold>(10), 1178&#8211;1189. 10.1001/jamaneurol.2017.2188 (2017).<pub-id pub-id-type="pmid">28846757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2017.2188</pub-id><pub-id pub-id-type="pmcid">PMC5759346</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosconi</surname><given-names>L</given-names></name><name name-style="western"><surname>Berti</surname><given-names>V</given-names></name><name name-style="western"><surname>Quinn</surname><given-names>C</given-names></name><name name-style="western"><surname>McHugh</surname><given-names>P</given-names></name><name name-style="western"><surname>Petrongolo</surname><given-names>G</given-names></name><name name-style="western"><surname>Varsavsky</surname><given-names>I</given-names></name><etal/></person-group><article-title>Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging</article-title><source>Neurology</source><year>2017</year><volume>89</volume><issue>13</issue><fpage>1382</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000004425</pub-id><pub-id pub-id-type="pmid">28855400</pub-id><pub-id pub-id-type="pmcid">PMC5652968</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Mosconi, L. et al. Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. <italic toggle="yes">Neurology</italic><bold>89</bold>(13), 1382&#8211;1390. 10.1212/WNL.0000000000004425 (2017).<pub-id pub-id-type="pmid">28855400</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000004425</pub-id><pub-id pub-id-type="pmcid">PMC5652968</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosconi</surname><given-names>L</given-names></name><name name-style="western"><surname>Berti</surname><given-names>V</given-names></name><name name-style="western"><surname>Dyke</surname><given-names>J</given-names></name><name name-style="western"><surname>Schelbaum</surname><given-names>E</given-names></name><name name-style="western"><surname>Jett</surname><given-names>S</given-names></name><name name-style="western"><surname>Loughlin</surname><given-names>L</given-names></name><etal/></person-group><article-title>Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition</article-title><source>Sci Rep.</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>10867</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-90084-y</pub-id><pub-id pub-id-type="pmid">34108509</pub-id><pub-id pub-id-type="pmcid">PMC8190071</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Mosconi, L. et al. Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition. <italic toggle="yes">Sci Rep.</italic><bold>11</bold>(1), 10867. 10.1038/s41598-021-90084-y (2021).<pub-id pub-id-type="pmid">34108509</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-90084-y</pub-id><pub-id pub-id-type="pmcid">PMC8190071</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viticchi</surname><given-names>G</given-names></name><name name-style="western"><surname>Falsetti</surname><given-names>L</given-names></name><name name-style="western"><surname>Buratti</surname><given-names>L</given-names></name><name name-style="western"><surname>Sajeva</surname><given-names>G</given-names></name><name name-style="western"><surname>Luzzi</surname><given-names>S</given-names></name><name name-style="western"><surname>Bartolini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Framingham risk score and the risk of progression from mild cognitive impairment to dementia</article-title><source>J. Alzheimers Dis.</source><year>2017</year><volume>59</volume><issue>1</issue><fpage>67</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.3233/JAD-170160</pub-id><pub-id pub-id-type="pmid">28582863</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Viticchi, G. et al. Framingham risk score and the risk of progression from mild cognitive impairment to dementia. <italic toggle="yes">J. Alzheimers Dis.</italic><bold>59</bold>(1), 67&#8211;75. 10.3233/JAD-170160 (2017).<pub-id pub-id-type="pmid">28582863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3233/JAD-170160</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suri</surname><given-names>S</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>CE</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>ME</given-names></name><name name-style="western"><surname>Germuska</surname><given-names>M</given-names></name><name name-style="western"><surname>Tunbridge</surname><given-names>EM</given-names></name><name name-style="western"><surname>Frisoni</surname><given-names>GB</given-names></name><etal/></person-group><article-title>Reduced cerebrovascular reactivity in young adults carrying the APOE &#949;4 allele</article-title><source>Alzheimers Dement.</source><year>2015</year><pub-id pub-id-type="doi">10.1016/j.jalz.2014.05.1755</pub-id><pub-id pub-id-type="pmid">25160043</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Suri, S. et al. Reduced cerebrovascular reactivity in young adults carrying the APOE &#949;4 allele. <italic toggle="yes">Alzheimers Dement.</italic>10.1016/j.jalz.2014.05.1755 (2015).<pub-id pub-id-type="pmid">25160043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jalz.2014.05.1755</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moreau</surname><given-names>KL</given-names></name><name name-style="western"><surname>Hildreth</surname><given-names>KL</given-names></name></person-group><article-title>Vascular aging across the menopause transition in healthy women</article-title><source>Adv. Vasc. Med.</source><year>2014</year><volume>2014</volume><issue>1</issue><fpage>204390</fpage><pub-id pub-id-type="pmid">25984561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/204390</pub-id><pub-id pub-id-type="pmcid">PMC4433172</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Moreau, K. L. &amp; Hildreth, K. L. Vascular aging across the menopause transition in healthy women. <italic toggle="yes">Adv. Vasc. Med.</italic><bold>2014</bold>(1), 204390 (2014).<pub-id pub-id-type="pmid">25984561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2014/204390</pub-id><pub-id pub-id-type="pmcid">PMC4433172</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>J</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name></person-group><article-title>Effect of menopause status on brain perfusion hemodynamics</article-title><source>Stroke</source><year>2024</year><volume>55</volume><issue>2</issue><fpage>260</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.123.044841</pub-id><pub-id pub-id-type="pmid">37850361</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Guo, W. et al. Effect of menopause status on brain perfusion hemodynamics. <italic toggle="yes">Stroke</italic><bold>55</bold>(2), 260&#8211;268. 10.1161/STROKEAHA.123.044841 (2024).<pub-id pub-id-type="pmid">37850361</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.123.044841</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenzweig</surname><given-names>N</given-names></name><name name-style="western"><surname>Kleemann</surname><given-names>KL</given-names></name><name name-style="western"><surname>Rust</surname><given-names>T</given-names></name><name name-style="western"><surname>Carpenter</surname><given-names>M</given-names></name><name name-style="western"><surname>Grucci</surname><given-names>M</given-names></name><name name-style="western"><surname>Aronchik</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer&#8217;s disease</article-title><source>Nat. Med.</source><year>2024</year><volume>30</volume><issue>10</issue><fpage>2990</fpage><lpage>3003</lpage><pub-id pub-id-type="doi">10.1038/s41591-024-03122-3</pub-id><pub-id pub-id-type="pmid">38961225</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Rosenzweig, N. et al. Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer&#8217;s disease. <italic toggle="yes">Nat. Med.</italic><bold>30</bold>(10), 2990&#8211;3003. 10.1038/s41591-024-03122-3 (2024).<pub-id pub-id-type="pmid">38961225</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-024-03122-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nemes</surname><given-names>S</given-names></name><name name-style="western"><surname>Logan</surname><given-names>PE</given-names></name><name name-style="western"><surname>Manchella</surname><given-names>MK</given-names></name><name name-style="western"><surname>Mundada</surname><given-names>NS</given-names></name><name name-style="western"><surname>La Joie</surname><given-names>R</given-names></name><name name-style="western"><surname>Polsinelli</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Sex and APOE &#949;4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer&#8217;s disease</article-title><source>Alzheimers Dement.</source><year>2023</year><volume>19</volume><issue>Suppl 9</issue><fpage>S49</fpage><lpage>S63</lpage><pub-id pub-id-type="doi">10.1002/alz.13403</pub-id><pub-id pub-id-type="pmid">37496307</pub-id><pub-id pub-id-type="pmcid">PMC10811272</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Nemes, S. et al. Sex and APOE &#949;4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer&#8217;s disease. <italic toggle="yes">Alzheimers Dement.</italic><bold>19</bold>(Suppl 9), S49&#8211;S63. 10.1002/alz.13403 (2023).<pub-id pub-id-type="pmid">37496307</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/alz.13403</pub-id><pub-id pub-id-type="pmcid">PMC10811272</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>